Scientific Sessions 2024  /  What’s the Latest in Interventional Cardiology? Clinical Trial and Science Update from TCT/ESC/AHA  /  ECLIPSE (primary results at TCT)
Logo

American Heart Association

  113
  0

Final ID:

ECLIPSE (primary results at TCT)

  • Kirtane, Ajay  ( Columbia University Medical Center , New York , New York , United States )
  • Stone, Gregg  ( Mount Sinai Hospital , Greenwich , Connecticut , United States )
    • Author Disclosures:
    Ajay Kirtane: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Dr. Kirtane reports Institutional funding to Columbia University and/or Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular, Amgen, CathWorks, CSI, Philips, ReCor Medical, Neurotronic, Biotronik, Chiesi, Bolt Medical, Magenta Medical, Canon, SoniVie, and Shockwave Medical. In addition to research grants, institutional funding includes fees paid to Columbia University and/or Cardiovascular Research Foundation for consulting and/or speaking engagements in which Dr. Kirtane controlled the content. Personal: Travel Expenses/Meals from Amgen, Medtronic, Biotronik, Boston Scientific, Abbott Vascular, CathWorks, Concept Medical, Edwards, CSI, Novartis, Philips, Abiomed, ReCor Medical, Chiesi, Zoll, Shockwave, and Regeneron.:Active (exists now) | Gregg Stone: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

What’s the Latest in Interventional Cardiology? Clinical Trial and Science Update from TCT/ESC/AHA

Saturday, 11/16/2024 , 03:15PM - 04:30PM

Hall

More abstracts on this topic:
DANGER-SHOCK (primary Results at TCT)

Moller Jacob, Thiele Holger

Panel Discussion

Hahn Rebecca

More abstracts from these authors:
Leveraging AI to Plan and Guide Physiology-Based PCI

Maehara Akiko, Kirtane Ajay

Ultrasound Renal Denervation in Hypertension – From Paradise to TIVUS

Kirtane Ajay, Bloch Michael

You have to be authorized to contact abstract author. Please, Login
Not Available